Ambit Biosciences , a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced operating results for the first quarter 2014.
http://ift.tt/1j0uXd3
http://ift.tt/1j0uXd3
No comments:
Post a Comment